Depending on cigarettes, counting on science

Scientist

Volumn 17, Issue 6, 2003, Pages 21-25

  Fogarty, Mignon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CYTOCHROME P450 2B6; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; GLUTAMIC ACID; NICOTINE; NICOTINIC RECEPTOR; NITRIC OXIDE; NORADRENALIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; VACCINE;

BRAIN REGION; CIGARETTE SMOKING; DEPRESSION; DISEASE PREDISPOSITION; DOPAMINE BRAIN LEVEL; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; HUMAN; NICOTINE REPLACEMENT THERAPY; NONHUMAN; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SCIENCE; SMOKING CESSATION; TOBACCO DEPENDENCE; VACCINATION; WITHDRAWAL SYNDROME;

NICOTIANA TABACUM;

EID: 0037464027     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. C. Lerman et al., "Tryptophan hydroxylase gene variant and smoking behavior," Am J Meg Genet, 105:518-20, 2001.
2. S. Hu et al., "Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior," Mol Psychiatry, 5:181-8, 2000.
3. E.F. McKinney et al., "Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers," Pharmacogenetics, 10:483-91, 2000.
4. C. Lerman et al., "Pharmacogenetic investigation of smoking cessation treatment." Pharmacogenetics, 12:627-34, November 2002.
5. S. Leonard et al., "Smoking and schizophrenia: abnormal nicotinic receptor expression," Eur J Pharmacol, 30:237-42, 2000.
6. K.P. Tercyak et al., "Interacting effects of depression and tobacco advertising receptivity on adolescent smoking." J Pediatr Psychol, 27:145-54, 2002.
7. American Lung Association. "Trends in tobacco use," 2002, available online at www.lungusa.org/data/smoke/SMK1.pdf.